MicroRNA-responsive ON-OFF hybrid mRNA switch for precise protein expression control
Messenger RNA (mRNA) technology is gaining attention for its potential in developing next-generation therapeutics. However, developing effective protein expression control technologies to regulate mRNA translation, particularly in a cell type- and tissue-specific manner, remains challenging. To achieve enhanced precision in translational regulation, we developed a microRNA (miRNA)-sensing hybrid mRNA switch, integrating an ON-type switch, which activates translation by detecting specific miRNAs expressed in target cells, into an OFF-type switch, which represses translation by sensing another miRNA in non-target cells. We first investigated effective module sequences after the poly(A)-tail for the ON-type mRNA switch to ensure appropriate translational activation in response to target cell-specific miRNAs. Moreover, the hybrid mRNA switch with a dual miRNA-sensing system reduced expression leakage in non-target cells and enhanced ON/OFF selectivity <i>in vitro</i> human cell cultures and <i>in vivo</i> mouse model. This ON-OFF hybrid mRNA switch technology allows for the selective expression of target proteins in designated cells and holds promise for the next generation of mRNA therapeutics.
Authors
- Yoshihiko Fujita (ORCID: https://orcid.org/0009-0006-2831-2964)
- Kaito Masaki
- Hirohide Saito (ORCID: https://orcid.org/0000-0002-8570-5784)
Institutions
- Kyoto University (JP)
- The University of Tokyo (JP)
Publication Details
- Journal
- Molecular Therapy — Nucleic Acids
- Published
- 2025-06-16
- DOI
- https://doi.org/10.1016/j.omtn.2025.102609
- Citations
- 4
- Primary Topic
- RNA Interference and Gene Delivery
- Type
- article
- Field-Weighted Citation Impact
- 3.22
Funders
- Japan Agency for Medical Research and Development
- Kyoto University
- Japan Society for the Promotion of Science
- Japan Science and Technology Agency
- Core Research for Evolutional Science and Technology